NEW YORK ( GenomeWeb) – Danaher reported today a 4 percent year over year  increase in total revenues paced by a 10 percent jump in the Life Sciences business.

For the three months ending March 29, total revenues were $4.88 billion compared to $4.70 billion in the year-ago period. It beat the analysts' average estimate of $4.79 billion.

Core revenue growth was 5.5 percent year over year. M&A added 2.5 percent to growth while currency effects decreased revenues by 4 percent, the firm said.